Several studies found that platelets may favor tumor development, either by expressing pro-angiogenic factors, such as vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) or by protecting tumoral cells by inhibiting natural killer cells [68]. This evidence concerns the gene VEGFA and neoplasm.